Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $5
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Craig Hettenbach maintains an Equal-Weight rating on Definitive Healthcare (NASDAQ:DH) but lowers the price target from $9 to $5.
August 06, 2024 | 4:24 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley analyst Craig Hettenbach maintains an Equal-Weight rating on Definitive Healthcare but lowers the price target from $9 to $5.
The lowered price target from $9 to $5 by a major financial institution like Morgan Stanley is likely to negatively impact investor sentiment and could lead to a short-term decline in the stock price of Definitive Healthcare.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100